RESPONSE TO PACLITAXEL IN ADENOID CYSTIC CARCINOMA OF THE SALIVARY GLANDSTILL, Brian G; MARTINS, Renato G.Head & neck. 2008, Vol 30, Num 6, pp 810-814, issn 1043-3074, 5 p.Article

Clinical Utility of Routine Proteinuria Evaluation in Treatment Decisions of Patients Receiving Bevacizumab for Metastatic Solid TumorsYEH, Jason; FRIEZE, Deborah; MARTINS, Renato et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 6, pp 1010-1015, issn 1060-0280, 6 p.Article

Bevacizumab in non-small cell lung cancer. DiscussionSANDLER, Alan; LYNCH, Thomas; HERBST, Roy et al.Clinical cancer research. 2007, Vol 13, Num 15, issn 1078-0432, 4613s-4616s, 2Conference Paper

A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non―Small-Cell Lung CancerHIRSCH, Fred R; KABBINAVAR, Fairooz; RUSK, Jason et al.Journal of clinical oncology. 2011, Vol 29, Num 26, pp 3567-3573, issn 0732-183X, 7 p.Article

A phase II study of weekly Paclitaxel in elderly patients with advanced non-small cell lung cancerFIDIAS, Panos; SUPKO, Jeffrey G; SKARIN, Arthur et al.Clinical cancer research. 2001, Vol 7, Num 12, pp 3942-3949, issn 1078-0432Article

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaive patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III studySCAGLIOTTI, Giorgio V; PARK, Keunchil; PATIL, Shekar et al.European journal of cancer (1990). 2009, Vol 45, Num 13, pp 2298-2303, issn 0959-8049, 6 p.Article

Erlotinib : Recent clinical results and ongoing studies in non-small cell lung cancer. DiscussionPEREZ-SOLER, Roman; LYNCH, Thomas; MARTINS, Renato et al.Clinical cancer research. 2007, Vol 13, Num 15, issn 1078-0432, 4689s-4592s, 2Conference Paper

Treatment of recurrent squamous cell carcinoma of the skin with cetuximabBAUMAN, Julie E; EATON, Keith D; MARTINS, Renato G et al.Archives of dermatology (1960). 2007, Vol 143, Num 7, pp 889-892, issn 0003-987X, 4 p.Article

Group A T-loop for differential moment mechanics : An implant studyPARSEKIAN MARTINS, Renato; BUSCHANG, Peter H; GONZAGA GANDINI, Luiz et al.American journal of orthodontics and dentofacial orthopedics. 2009, Vol 135, Num 2, pp 182-189, issn 0889-5406, 8 p.Article

Safety and Activity of Anti―PD-L1 Antibody in Patients with Advanced CancerBRAHMER, Julie R; TYKODI, Scott S; PITOT, Henry C et al.The New England journal of medicine. 2012, Vol 366, Num 26, pp 2455-2465, issn 0028-4793, 11 p.Article

Antibodies to the epidermal growth factor receptor in non-small cell lung cancer : Current status of matuzumab and panitumumab. DiscussionSOCINSKI, Mark A; SANDIER, Alan; LYNCH, Thomas et al.Clinical cancer research. 2007, Vol 13, Num 15, issn 1078-0432, 4597s-4601s, 2Conference Paper

Erlotinib in previously treated non-small-cell lung cancerSHEPHERD, Frances A; PEREIRA, José Rodrigues; VAN KOOTEN, Maximiliano et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 123-132, issn 0028-4793, 10 p.Article

Optimizing the design of preactivated titanium T-loop springs with Loop softwarePARSEKIAN MARTINS, Renato; BUSCHANG, Peter H; PARSEKIAN MARTINS, Lidia et al.American journal of orthodontics and dentofacial orthopedics. 2008, Vol 134, Num 1, pp 161-166, issn 0889-5406, 6 p.Article

Skeletal and dental components of Class II correction with the bionator and removable headgear splint appliancesPARSEKIAN MARTINS, Renato; DA ROSA MARTINS, Joel Claudio; PARSEKIAN MARTINS, Lidia et al.American journal of orthodontics and dentofacial orthopedics. 2008, Vol 134, Num 6, pp 732-741, issn 0889-5406, 10 p.Article

Biomonitoring of oral epithelial cells in petrol station attendants: Comparison between buccal mucosa and lateral border of the tongueMARTINS, Renato A; DA SILVA GOMES, Guilherme A; AGUIAR, Odair et al.Environment international. 2009, Vol 35, Num 7, pp 1062-1065, issn 0160-4120, 4 p.Article

Changes over time in canine retraction: An implant studyPARSEKIAN MARTINS, Renato; BUSCHANG, Peter H; GONZAGA GANDINI, Luiz et al.American journal of orthodontics and dentofacial orthopedics. 2009, Vol 136, Num 1, pp 87-93, issn 0889-5406, 7 p.Article

Novel agents in the treatment of lung cancer: advances in EGFR-targeted agents: Proceedings of the Third Cambridge Conference, Cambridge, Massachusetts, September 23-24, 2005LYNCH, Thomas J; ENGELMAN, Jeffrey A; EVANS, Tracey L et al.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 100 p., 2Conference Proceedings

Midsymphyseal distraction osteogenesis : A new alternative for the treatment of dental crowdingGONZAGA GANDINI, Luiz; PARSEKIAN MARTINS, Renato; AZEVEDO DE OLIVEIRA, Cristina et al.American journal of orthodontics and dentofacial orthopedics. 2009, Vol 135, Num 4, pp 530-535, issn 0889-5406, 6 p.Article

Mouse models of lung cancerDUTT, Amit; WONG, Kwok-Kin.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4396s-4402s, 2Conference Paper

Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non - small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitorsJÄNNE, Pasi A; JOHNSON, Bruce E.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4416s-4420s, 2Conference Paper

Novel combinations based on epidermal growth factor receptor inhibitionADJEI, Alex A.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4446s-4450s, 2Conference Paper

The evolving role of cetuximab in non-small cell lung cancerLILENBAUM, Rogerio C.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4432s-4435s, 2Conference Paper

Combining targeted agents : Blocking the epidermal growth factor and vascular endothelial growth factor pathwaysSANDLER, Alan; HERBST, Roy.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4421s-4425s, 2Conference Paper

Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancerJOHNSON, Bruce E; JÄNNE, Pasi A.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4436s-4440s, 2Conference Paper

Targeted therapies in combination with chemotherapy in non-small cell lung cancerJOHNSON, David H.Clinical cancer research. 2006, Vol 12, Num 14, issn 1078-0432, 4451s-4457s, 2Conference Paper